- Targeted protein’s preprocessing and refinement can be per-
form by other tools like Schrodinger Protein preparation wiz-
ard (https://www.schrodinger.com/protein-preparation-
wizard) and 3D refine web server (http://sysbio.rnet.mis
souri.edu/3Drefine/)[89–91]. - The physical–chemical and pharmaceutical properties [92] can
also be predicted for de novo designed ligands using some tools
like QikProp (https://www.schrodinger.com/qikprop)[93],
TOPKAT (http://accelrys.com/products/collaborative-sci
ence/biovia-discovery-studio/qsar-admet-and-predictive-toxi
cology.html)[94] SwissADME (https://www.swissadme.ch)
[95] and admetSAR (http://lmmd.ecust.edu.cn:8000/)
[96]. These tools are effective and possess wide range of prop-
erties to predict more insights on the ligands. - Prior to docking study, the newly designed compounds could
be prepared using LigPrep utility of Schrodinger’s package
[89, 97], which produces all feasible tautomeric, stereochemi-
cal, and ionization variants of the participation molecules fol-
lowed by energy minimization to achieve structures with
optimized geometry. - The synthetic accessibility of a compound can be predicted
with the help of several computational approaches such as
myPresto—Medicinally Yielding PRotein Engineering Simula-
TOr program suite (http://presto.protein.osaka-u.ac.jp/
myPresto4/) and SYLVIA (https://www.mn-am.com/
products/sylvia)[98]. - Prediction of binding free energy of the newly designed against
protein target through MM/GBSA [Molecular Mechanics
Generalized Born Surface Area continuum solvation] would
give higher clarity than docking scores in silico or in vitro
processing [99] - Characterization of newly designed ligands through Density
functional theory calculation on chemical properties such as
molecular electrostatic potential (MESP), highest occupied
molecular orbitals (HOMOs) and lowest unoccupied molecu-
lar orbitals (LUMOs), and aqueous solvation energy would
provide key mechanistic insights on ligands which will we
very useful in screening the newly designed ligands before
further processing [100].
Acknowledgment
SKS thanks Department of Biotechnology (DBT), New Delhi for
providing financial support. VS and UP gratefully acknowledge
DST (New Delhi) for INSPIRE Senior Research Fellowship
De Novo Design of Ligands 81